Church & Dwight is a leading consumer goods company producing household and personal care products.
It has built a strong portfolio of trusted brands, known for its strategic acquisitions and focus on value-driven essentials like Arm & Hammer baking soda.
Updated: January 14, 2026, 16:00 EST
Technical Analysis CHD shows signs of stabilization with a 5.27% rebound over the past month, though it remains 24.5% below its 52-week high. Its low beta of 0.46 confirms defensive characteristics, but the significant maximum drawdown of -27.92% highlights vulnerability during market downturns. The stock's position near the lower end of its annual range suggests potential oversold conditions.
Fundamental Analysis CHD exhibits solid revenue growth and maintains strong profitability with an 11.5% net profit margin. The company's financial health is sound with manageable debt levels and adequate liquidity, though operational efficiency metrics like ROE (4.3%) indicate room for improvement. Effective working capital management supports stable cash flow generation.
Valuation Assessment Valuation presents mixed signals: while the forward P/E of 29.35 reflects high growth expectations, the negative PEG ratio (-7.63) and elevated EV/EBITDA (66.94) raise concerns about earnings sustainability. The P/B ratio of 4.93 suggests the market values CHD's strong brand portfolio, but current multiples demand careful scrutiny given modest growth projections.
Risk Evaluation CHD's low beta provides downside protection during market volatility, though the substantial maximum drawdown indicates meaningful downside risk remains. The absence of significant short interest reduces near-term speculative pressure, but investors should monitor potential liquidity constraints given the stock's defensive nature.
CHD presents a compelling case for conservative investors seeking stability in consumer staples. The company's strong brand portfolio, consistent revenue growth, and defensive characteristics provide a buffer against market volatility. While current valuation multiples appear stretched, the stock's oversold technical position and sound fundamentals support a strategic accumulation approach. Investors with a long-term horizon may find CHD attractive for its resilient business model and potential for gradual recovery.
Of course. Here is a 12-month outlook for Church & Dwight Co., Inc. (CHD).
12-Month Outlook for CHD:
Over the next 12 months, CHD's outlook is stable with a bias toward gradual recovery. Key catalysts will be the defensive nature of its essential consumer brands, which typically hold up well during economic uncertainty, and its solid fundamentals supporting continued execution. The primary risk is its elevated valuation; the stock remains susceptible to further multiple compression if its modest earnings growth fails to justify the high forward P/E ratio. Given the current technical oversold position and the absence of a specific analyst target, a reasonable target range appears to be $95 - $105, contingent on a broader market rally and sustained consumer spending.
Most Wall Street analysts are optimistic about CHD's 12-month outlook, with consensus target around $90.16, indicating expected upside potential.
Overall, CHD has investment potential but also faces challenges. Here are key factors to weigh before investing.
CHD has demonstrated mixed performance with recent stabilization but remains significantly below its 52-week high. The stock shows moderate recent gains while continuing to underperform the broader market on a relative basis.
Short-term performance reveals a notable 5.27% rebound over the past month, though the three-month change remains relatively flat at 0.4%. Despite this recent strength, CHD has underperformed the market by 2.97% over the three-month period, indicating relative weakness despite positive absolute returns.
Currently trading at $87.97, CHD sits just 8.2% above its 52-week low and remains 24.5% below its peak, positioning it in oversold territory within its annual range. The stock's low beta of 0.46 confirms its defensive characteristics, though the maximum drawdown of -27.92% highlights the significant downside experienced during the past year.
| Period | CHD Return | S&P 500 |
|---|---|---|
| 1m | +6.6% | +1.3% |
| 3m | +2.8% | +5.7% |
| 6m | -8.4% | +10.6% |
| 1y | -12.8% | +16.5% |
| ytd | +9.1% | +1.1% |
Revenue & Profitability CHD demonstrated solid revenue growth in Q3 2025, increasing from $1.51 billion to $1.59 billion quarter-over-quarter. The company maintained strong profitability with a net profit margin of 11.5%, though this was a slight decrease from the prior quarter's 12.7%, primarily due to higher operating expenses.
Financial Health The company's debt management appears sound, with a manageable debt-to-equity ratio of 56% and an interest coverage ratio of 5.44x. CHD maintains adequate liquidity with a current ratio of 1.09, though the quick ratio of 0.66 suggests some reliance on inventory to meet short-term obligations.
Operational Efficiency Operational efficiency shows room for improvement, with a modest return on equity of 4.3% and an asset turnover ratio of 0.17. The cash conversion cycle of 21 days indicates effective working capital management, while the fixed asset turnover of 1.69 suggests reasonable utilization of long-term assets.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the provided metrics, CHD appears overvalued relative to historical earnings power but reasonably valued on a forward-looking basis. The trailing P/E of 26.59 is elevated, suggesting a premium valuation for past earnings, while the forward P/E of 29.35 indicates continued high expectations. The significantly negative PEG ratio (-7.63) is a major concern, signaling that earnings growth is negative and failing to justify the high earnings multiple, which is further corroborated by an exceptionally high EV/EBITDA of 66.94, pointing to expensive cash flow generation.
A peer comparison against industry averages is not possible with the provided data. However, the price-to-sales (P/S) ratio of 3.39 and price-to-book (P/B) ratio of 4.93 must be assessed independently. A P/B near 5 implies the market values the company's assets at a substantial premium to their accounting value, which is typically justified only by strong brand intangible assets or exceptional profitability. The P/S ratio suggests investors are paying a significant multiple for each dollar of revenue, which must be weighed against the company's net profit margin to determine if it is appropriate.
CHD's beta of 0.46 indicates significantly lower volatility than the broader market, suggesting the stock is relatively stable and less reactive to market swings. However, the 1-year maximum drawdown of -27.92% reveals that the stock still experienced substantial peak-to-trough declines during market stress, implying investors should be prepared for potential losses despite its low beta.
With no reported short interest, there is little speculative betting against the stock, reducing near-term pressure from forced covering rallies. However, the absence of short interest data could also indicate lower liquidity or analyst coverage, potentially leading to larger spreads or slower price discovery during market events.
Neutral. While CHD shows defensive characteristics with its low beta and has recent positive catalysts like an analyst upgrade, it faces headwinds from institutional selling and a high valuation with negative earnings growth (PEG ratio of -7.63). The stock is best suited for patient, long-term investors who believe in the company's strategic refocusing and can tolerate near-term volatility from portfolio changes.
Based on the provided data, CHD stock appears to be overvalued.
The valuation is stretched, with a trailing P/E of 26.59 and a forward P/E of 29.35, both indicating high earnings expectations. Key metrics like the Price-to-Book ratio of 4.93 and Price-to-Sales ratio of 3.39 suggest the market is pricing the company at a significant premium to its asset and revenue base. The most critical warning sign is the deeply negative PEG ratio of -7.63, which signals that earnings growth is not supporting the high P/E multiple.
The primary reason for this overvaluation is a disconnect between the stock's price and its underlying financial performance. While the company shows solid revenue growth and profitability (11.5% net margin), its operational efficiency is mediocre (Return on Equity of only 4.3%), failing to justify the premium valuation multiples investors are currently paying.
Based on the provided information, here are the key risks of holding CHD stock, ordered by importance:
1. Industry Underperformance Risk: The stock's significant underperformance relative to the broader market, trading 24.5% below its 52-week high, indicates persistent sector or company-specific challenges that may continue to limit upside potential. 2. Limited Liquidity and Coverage Risk: The absence of reported short interest suggests potentially lower trading liquidity and analyst coverage, which could lead to larger bid-ask spreads and slower price discovery during market events. 3. Profitability Pressure Risk: The recent decline in net profit margin from 12.7% to 11.5% signals rising cost pressures or competitive challenges that could threaten future earnings stability. 4. Operational Efficiency Risk: A low return on equity of 4.3% and asset turnover ratio of 0.17 indicate potential inefficiencies in generating profits from shareholder equity and assets, which may hinder long-term growth.
Based on the provided financial health and stable outlook, here is a forecast for CHD stock through 2026.
My forecast projects a base case target range of $110-$125 and a bull case of $130-$140 by the end of 2026, driven by consistent execution, the defensive nature of its essential brands, and gradual margin stabilization. The main assumptions are that consumer spending remains resilient, allowing CHD to leverage its strong portfolio for modest top-line growth while managing costs effectively. It is important to note that this forecast is speculative; the primary uncertainty stems from its persistently high valuation, which requires sustained earnings growth to prevent multiple compression and limits significant upside potential.